Literature DB >> 7786769

Low molecular weight heparin(s).

T W Barrowcliffe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786769     DOI: 10.1111/j.1365-2141.1995.tb03373.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Anticoagulation in patients with thromboembolic disease.

Authors:  R C Tait
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations.

Authors:  M T Nurmohamed; H ten Cate; J W ten Cate
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

3.  A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin.

Authors:  Junxin Wang; Fang Chen; Santiago J Arconada-Alvarez; James Hartanto; Li-Peng Yap; Ryan Park; Fang Wang; Ivetta Vorobyova; Grant Dagliyan; Peter S Conti; Jesse V Jokerst
Journal:  Nano Lett       Date:  2016-09-28       Impact factor: 11.189

Review 4.  Manipulation of coagulation factors in acute stroke.

Authors:  J F Meschia; J Biller
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 5.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

6.  Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation.

Authors:  Zhenqing Zhang; Michel Weïwer; Boyangzi Li; Melissa M Kemp; Tyler H Daman; Robert J Linhardt
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

Review 7.  Analysis and characterization of heparin impurities.

Authors:  Szabolcs Beni; John F K Limtiaco; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-03       Impact factor: 4.142

8.  Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.

Authors:  Mohammed Alquwaizani; Leo Buckley; Christopher Adams; John Fanikos
Journal:  Curr Emerg Hosp Med Rep       Date:  2013-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.